Ng IO - Search Results

1

Deleted in liver cancer 1 (DLC1) negatively regulates Rho/ROCK/MLC pathway in hepatocellular carcinoma.

Wong CC, Wong CM, Ko FC, Chan LK, Ching YP, Yam JW, Ng IO. Wong CC, et al. Among authors: ng io. PLoS One. 2008 Jul 23;3(7):e2779. doi: 10.1371/journal.pone.0002779. PLoS One. 2008. PMID: 18648664 Free PMC article.

2

Deleted in liver cancer (DLC) 2 encodes a RhoGAP protein with growth suppressor function and is underexpressed in hepatocellular carcinoma.

Ching YP, Wong CM, Chan SF, Leung TH, Ng DC, Jin DY, Ng IO. Ching YP, et al. Among authors: ng io, ng dc. J Biol Chem. 2003 Mar 21;278(12):10824-30. doi: 10.1074/jbc.M208310200. Epub 2003 Jan 16. J Biol Chem. 2003. PMID: 12531887 Free article.

3

Genetic and epigenetic alterations of DLC-1 gene in hepatocellular carcinoma.

Wong CM, Lee JM, Ching YP, Jin DY, Ng IO. Wong CM, et al. Among authors: ng io. Cancer Res. 2003 Nov 15;63(22):7646-51. Cancer Res. 2003. PMID: 14633684

4

Evaluation of nuclear factor-kappaB, urokinase-type plasminogen activator, and HBx and their clinicopathological significance in hepatocellular carcinoma.

Chan CF, Yau TO, Jin DY, Wong CM, Fan ST, Ng IO. Chan CF, et al. Among authors: ng io. Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):4140-9. doi: 10.1158/1078-0432.CCR-03-0574. Clin Cancer Res. 2004. PMID: 15217951

5

HDPR1, a novel inhibitor of the WNT/beta-catenin signaling, is frequently downregulated in hepatocellular carcinoma: involvement of methylation-mediated gene silencing.

Yau TO, Chan CY, Chan KL, Lee MF, Wong CM, Fan ST, Ng IO. Yau TO, et al. Among authors: ng io. Oncogene. 2005 Feb 24;24(9):1607-14. doi: 10.1038/sj.onc.1208340. Oncogene. 2005. PMID: 15580286

6

Association of MAD2 expression with mitotic checkpoint competence in hepatoma cells.

Sze KM, Ching YP, Jin DY, Ng IO. Sze KM, et al. Among authors: ng io. J Biomed Sci. 2004 Nov-Dec;11(6):920-7. doi: 10.1007/BF02254377. J Biomed Sci. 2004. PMID: 15591789

7

The liver-enriched transcription factor CREB-H is a growth suppressor protein underexpressed in hepatocellular carcinoma.

Chin KT, Zhou HJ, Wong CM, Lee JM, Chan CP, Qiang BQ, Yuan JG, Ng IO, Jin DY. Chin KT, et al. Among authors: ng io. Nucleic Acids Res. 2005 Mar 30;33(6):1859-73. doi: 10.1093/nar/gki332. Print 2005. Nucleic Acids Res. 2005. PMID: 15800215 Free PMC article.

8

Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma.

Wong CM, Yam JW, Ching YP, Yau TO, Leung TH, Jin DY, Ng IO. Wong CM, et al. Among authors: ng io. Cancer Res. 2005 Oct 1;65(19):8861-8. doi: 10.1158/0008-5472.CAN-05-1318. Cancer Res. 2005. PMID: 16204057 Free article.

9

Deleted in liver cancer 2 (DLC2) suppresses cell transformation by means of inhibition of RhoA activity.

Leung TH, Ching YP, Yam JW, Wong CM, Yau TO, Jin DY, Ng IO. Leung TH, et al. Among authors: ng io. Proc Natl Acad Sci U S A. 2005 Oct 18;102(42):15207-12. doi: 10.1073/pnas.0504501102. Epub 2005 Oct 10. Proc Natl Acad Sci U S A. 2005. PMID: 16217026 Free PMC article.

10

Mitochondrial targeting of growth suppressor protein DLC2 through the START domain.

Ng DC, Chan SF, Kok KH, Yam JW, Ching YP, Ng IO, Jin DY. Ng DC, et al. Among authors: ng io. FEBS Lett. 2006 Jan 9;580(1):191-8. doi: 10.1016/j.febslet.2005.11.073. Epub 2005 Dec 9. FEBS Lett. 2006. PMID: 16364308 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

440 results

Search Page

Filters